{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "Q126P",
          "position": "126"
        },
        "variant_string_id": "PINK1 Q126P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 and Parkin disrupt the PINK1/Parkin-mediated mitophagy and therefore underline the potential importance of this pathway in the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the disruption of PINK1/Parkin-mediated mitophagy in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used co-immunoprecipitation, western blot, and cellular transfection assays to investigate the impact of PINK1 mutations on Parkin binding and mitophagy.",
          "judgment": "Yes",
          "reasoning": "These assays are standard methods for studying protein-protein interactions and cellular functions, which are applicable to understanding the pathogenic mechanisms of PINK1 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of specific mutants, transfections, and assays with appropriate controls, indicating a valid experimental approach."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "Quantification of Parkin translocation to damaged mitochondria and mitochondrial clearance was described previously. Statistical significance was assessed by two-tailed paired student’s-t-test.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis of the functional assays, allowing for the estimation of the effect size of the PINK1 Q126P variant on mitophagy."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While statistical analysis was performed, direct calculation or reporting of OddsPath is not mentioned in the provided text."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "N/A",
            "reasoning": "Direct OddsPath calculation is not provided in the paper."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 Q126P variant shows reduced binding to Parkin and impairs mitophagy, which is a key pathway in Parkinson's disease. The functional assays support the pathogenicity of this variant, leading to the assignment of PS3_supporting evidence strength."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "L347P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 and Parkin disrupt the PINK1/Parkin-mediated mitophagy and therefore underline the potential importance of this pathway in the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the disruption of PINK1/Parkin-mediated mitophagy in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used co-immunoprecipitation, western blot, and cellular transfection assays to investigate the impact of PINK1 mutations on Parkin binding and mitophagy.",
          "judgment": "Yes",
          "reasoning": "These assays are standard methods for studying protein-protein interactions and cellular functions, which are applicable to understanding the pathogenic mechanisms of PINK1 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of specific mutants, transfections, and assays with appropriate controls, indicating a valid experimental approach."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "Quantification of Parkin translocation to damaged mitochondria and mitochondrial clearance was described previously. Statistical significance was assessed by two-tailed paired student’s-t-test.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis of the functional assays, allowing for the estimation of the effect size of the PINK1 L347P variant on mitophagy."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While statistical analysis was performed, direct calculation or reporting of OddsPath is not mentioned in the provided text."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "N/A",
            "reasoning": "Direct OddsPath calculation is not provided in the paper."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 L347P variant shows reduced binding to Parkin and impairs mitophagy, which is a key pathway in Parkinson's disease. The functional assays support the pathogenicity of this variant, leading to the assignment of PS3_supporting evidence strength."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Wild-type",
          "alt": "W437X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 and Parkin disrupt the PINK1/Parkin-mediated mitophagy and therefore underline the potential importance of this pathway in the pathogenesis of PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the disruption of PINK1/Parkin-mediated mitophagy in Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used co-immunoprecipitation, western blot, and cellular transfection assays to investigate the impact of PINK1 mutations on Parkin binding and mitophagy.",
          "judgment": "Yes",
          "reasoning": "These assays are standard methods for studying protein-protein interactions and cellular functions, which are applicable to understanding the pathogenic mechanisms of PINK1 mutations.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of specific mutants, transfections, and assays with appropriate controls, indicating a valid experimental approach."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "Quantification of Parkin translocation to damaged mitochondria and mitochondrial clearance was described previously. Statistical significance was assessed by two-tailed paired student’s-t-test.",
            "judgment": "Yes",
            "reasoning": "The paper provides statistical analysis of the functional assays, allowing for the estimation of the effect size of the PINK1 W437X variant on mitophagy."
          },
          "sub_step_4b": {
            "step_name": "Sub-step 4b: No OddsPath Calculation",
            "judgment": "No",
            "reasoning": "While statistical analysis was performed, direct calculation or reporting of OddsPath is not mentioned in the provided text."
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "judgment": "N/A",
            "reasoning": "Direct OddsPath calculation is not provided in the paper."
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The PINK1 W437X variant shows more pronounced initial mitochondrial localization even in the absence of mitochondrial damage and affects Parkin translocation and mitophagy, which are key pathways in Parkinson's disease. The functional assays support the pathogenicity of this variant, leading to the assignment of PS3_supporting evidence strength."
    }
  ]
}